Shopping Cart
- Remove All
- Your shopping cart is currently empty
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $540 | In Stock | |
5 mg | $1,380 | In Stock | |
10 mg | $2,230 | In Stock |
Description | Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease. |
In vivo | 'Crizanlizumab (1 or 6 mg/kg; intraperitoneal injection; three times a week; for 5 months) improves sickle cell retinopathy in 4-week-old male HbSS (sickle cell disease) mice[2].' |
Alias | SEG-101, ADAKVEO |
Molecular Weight | 150 kDa |
Cas No. | 1690318-25-2 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.